
March 24, 2026
CVS Health To Settle PBM Lawsuit With FTC CVS Health’s Caremark has become the second of the Big 3 pharmacy benefit managers (PBMs) to reach a settlement with the Federal Trade Commission (FTC) over insulin pricing. A court document filed Monday indicates the parties have requested that the matter be withdrawn “for the purpose of considering a proposed consent agreement.” No details on the settlement were made public, but the concessions likely mirror the far-reaching elements agreed to earlier by Cigna’s Express Scripts PBM. United’s OptumRx PBM will undoubtedly have to settle too. Additional articles: https://www.fiercehealthcare.com/payers/cvs-caremark-ftc-reach-settlement-insulin-pricing-case and https://www.healthcaredive.com/news/cvs-caremark-ftc-proposed-settlement-insulin-lawsuit/815581/ (Some articles may require a subscription.) #ftc #cvshealth #pbms #insulin #drugpricing https://www.modernhealthcare.com/politics-regulation/mh-cvs-health-ftc-insulin-rebate-lawsuit/ Trump Administration Launches ASPIRE Model The Centers for Medicare and Medicaid Services (CMS) announced a new model called ASPIRE. It will promote wraparound services for high-risk Medicaid and Children’s Health Insurance Plan enrollees through a payment demonstration. CMS will provide



